In conclusion, we provide evidence for the upregulation of PD-L1 in MDS cells as a consequence of cognate and non-cognate interactions between MDS cells and autologous tumor-specific T cells, and that the de novo surface expression of PD-L1 on MDS cells is not sufficient on inhibit T-cell-mediated killing. The gene discussed is CD274; the disease is myelodysplastic syndrome.